Chediak-Higashi Syndrome Recruiting Phase 2 Trials for Melphalan (DB01042)

Also known as: Begnez Cesar disease / Alder (granulation) (granulocyte) anomaly

IndicationStatusPhase
DBCOND0029163 (Chediak-Higashi Syndrome)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01821781Immune Disorder HSCT ProtocolTreatment